Literature DB >> 26227592

Characterization and Sequencing of a Genotype XII Newcastle Disease Virus Isolated from a Peacock (Pavo cristatus) in Peru.

Ana Chumbe1, Ray Izquierdo-Lara2, Luis Tataje-Lavanda2, Aling Figueroa2, Karen Segovia3, Rosa Gonzalez3, Giovana Cribillero3, Angela Montalvan2, Manolo Fernández-Díaz2, Eliana Icochea3.   

Abstract

Here, we report the first complete sequence and biological characterization of a Newcastle disease virus (NDV) isolated from a peacock in South America (NDV/peacock/Peru/2011). This isolate, classified as genotype XII in class II, highlights the need for increased surveillance of noncommercial avian species.
Copyright © 2015 Chumbe et al.

Entities:  

Year:  2015        PMID: 26227592      PMCID: PMC4520891          DOI: 10.1128/genomeA.00792-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Newcastle disease virus (NDV) is able to infect >250 species of birds worldwide and is also responsible for an acute and very contagious respiratory disease. NDV (genus Avulavirus, family Paramixoviridae) possesses a negative-sense single-stranded RNA genome. Wild birds have been implicated in the spread of the disease to domestic birds (1). Based on sequence analysis of the fusion protein (F) gene, NDV strains are classified in class I or II. Strains of class I are avirulent in chickens, whereas strains in class II can be lentogenic, mesogenic, or velogenic. Class II is subdivided into at least 18 genotypes from I to XVIII (2). Several outbreaks have been observed in Peru in recent years, but information regarding which genotypes are circulating is poor. In 2011, 9 out of 10 peacocks (Pavo cristatus) died in a zoo farm in Huachipa, Lima, Peru, with nervous and respiratory symptoms. The virus isolation, from oral and cloacal swabs, was carried out in 9-day-old embryonated specific-pathogen-free (SPF) chicken eggs. Allantoic fluid (AF) was collected and assessed by hemagglutination and a hemagglutination inhibition test using NDV hyperimmune serum. Amplified AF was clarified, aliquoted, stored at −80°C, and quantified by plaque assay. The 50% lethal dose (LD50) was calculated in 4-week-old SPF chickens by 10-fold serial dilutions. The intracerebral pathogenicity index (ICPI) was calculated according to standard protocols (3). All protocols that included animals were approved by the Institutional Animal Care and Use Committee of the Universidad Nacional Mayor de San Marcos (UNMSM), Lima, Peru. The complete sequence of NDV/peacock/Peru/2011 was amplified by 8 pairs of overlapping oligonucleotide primers using the OneStep reverse transcription-PCR (RT-PCR) kit (Qiagen). Purified amplicons were cloned into the pGEM-T Easy (Promega) and sequenced with T7/SP6 primers. The assembly and alignment were made on SnapGene and Clustal W, respectively. Phylogenetic analysis and sequences comparison were done in MEGA 6.0. Sequence analysis showed that the genome of NDV/peacock/Peru/2011 is 15,192 nucleotides (nt) long, with an insertion of 6 nt (CTCCAC) after position 1647 in the 5′ noncoding region of the nucleoprotein gene, compared with the LaSota strain (GenBank accession no. AF077761.1). Phylogenetic analysis of the complete coding region of the F gene placed the isolate within genotype XII in class II, together with the poultry/Peru/1918-03/2008 strain (GenBank accession no. JN800306.1), which was previously also isolated in Peru (4). A comparison of the complete genome sequences showed that the highest genetic identity (98.7%) was observed with poultry/Peru/1918-03/2008, while only 82.1% was observed with the LaSota strain. A comparison between the LD50 (106.72/ml) and the number of PFU revealed that at least 2 × 102 PFU per chicken are required to kill 100% (5/5 chickens), and 20 PFU are able to kill 60% (3/5 chickens). The isolate showed an ICPI of 1.80, characteristic of velogenic NDV strains. These characteristics are consistent with the presence of a polybasic amino acid motif (112RRQKR↓F117) at the fusion protein cleavage site, which is considered a major molecular determinant of virulence for NDV (5). The elucidation of the complete genome sequence of NDV/peacock/Peru/2011 will help us further study the epidemiology and molecular pathogenesis of genotype XII and aid in the development of a vaccine candidate against homologous genotypes that are circulating in Peru.

Nucleotide sequence accession number.

The complete genome sequence of NDV/peacock/Peru/2011 has been deposited in GenBank under the accession no. KR732614. The version described in this paper is the first version.
  4 in total

Review 1.  Newcastle disease and other avian paramyxoviruses.

Authors:  D J Alexander
Journal:  Rev Sci Tech       Date:  2000-08       Impact factor: 1.181

2.  High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: cocirculation of genotype XIV and newly defined genotypes XVII and XVIII.

Authors:  Chantal J Snoeck; Ademola A Owoade; Emmanuel Couacy-Hymann; Bello R Alkali; Mbah P Okwen; Adeniyi T Adeyanju; Giscard F Komoyo; Emmanuel Nakouné; Alain Le Faou; Claude P Muller
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Complete genome and clinicopathological characterization of a virulent Newcastle disease virus isolate from South America.

Authors:  Diego G Diel; Leonardo Susta; Stivalis Cardenas Garcia; Mary L Killian; Corrie C Brown; Patti J Miller; Claudio L Afonso
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

4.  Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence.

Authors:  B P Peeters; O S de Leeuw; G Koch; A L Gielkens
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

  4 in total
  3 in total

1.  Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein.

Authors:  Ana Chumbe; Ray Izquierdo-Lara; Katherine Calderón; Manolo Fernández-Díaz; Vikram N Vakharia
Journal:  Virol J       Date:  2017-11-23       Impact factor: 4.099

2.  Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.

Authors:  Ray Izquierdo-Lara; Ana Chumbe; Katherine Calderón; Manolo Fernández-Díaz; Vikram N Vakharia
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

3.  A Recombinant Turkey Herpesvirus Expressing the F Protein of Newcastle Disease Virus Genotype XII Generated by NHEJ-CRISPR/Cas9 and Cre-LoxP Systems Confers Protection against Genotype XII Challenge in Chickens.

Authors:  Katherine Calderón; Aldo Rojas-Neyra; Brigith Carbajal-Lévano; Luis Luján-Valenzuela; Julio Ticona; Gisela Isasi-Rivas; Angela Montalvan; Manuel Criollo-Orozco; Edison Huaccachi-Gonzáles; Luis Tataje-Lavanda; Karla Lucia F Alvarez; Manolo Fernández-Sánchez; Manolo Fernández-Díaz; Na Tang; Yongxiu Yao; Venugopal Nair
Journal:  Viruses       Date:  2022-04-11       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.